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To determine whether protoporphyric liver injury affects hepatic dendritic cells (DC)
and Kupffer cells, we examined liver tissues of griseofulvin-induced protoporphyric
mice using histological and immunohistochemical methods.  After 1 week of griseofulvin
feeding, the protoporphyric liver showed prominent hepatomegaly and a gradual in-
crease in histopathological changes such as hepatocellular hypertrophy, focal necrosis
and brown pigment deposits.  After 4 weeks of treatment, marked ductular reaction
was observed in the liver tissue.  Immunohistochemical analyses indicated that the den-
sity of NLDC-145-positive hepatic DC gradually decreased during griseofulvin feeding.
However, the index of the number of DC in the whole liver appeared to fall sharply
after 6 weeks.  In contrast, the density of F4/80-positive Kupffer cells gradually increased
during griseofulvin feeding.  In the spleen and lung, no significant differences were
noted in the distribution of NLDC-145-positive DC between experimental and control
mice.  These results suggested that griseofulvin-induced protoporphyria leads to a
specific decrease in the density of hepatic DC due to hepatomegaly until 4 weeks of
treatment and is substantial after 6 weeks.  This substantial decrease of hepatic DC
might have been induced by some alterations in protoporphyric liver injury including
ductular reaction at a later stage in this experiment.  Since hepatic DC were reduced in
number, they seemed to have no significant relation to the progression of griseofulvin-
induced protoporphyric liver injury.  However, the decrease of hepatic DC might affect
the cellular immune response in protoporphyria.
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Although human porphyrias are often associ-
ated with the development of liver injury, they
are relatively uncommon, preventing adequate
investigation in patients.  Griseofulvin, an anti-
fungal drug, is known to inhibit hepatic fer-
rochelatase activity (Lochhead et al., 1967) and
disturb porphyrin metabolism in the mouse (De
Matteis and Rimington, 1963).  This experi-
mental mouse model shows liver injury with
accumulation of brown protoporphyrin crystals,
resembling human erythropoietic protopor-
phyria.  This mouse model has therefore been
used to study the pathogenesis of protopor-
phyric liver injury (Matilla and Molland, 1974;
Gschnait et al., 1975; Denk et al., 1979; Kawahara
et al., 1989; Woltsche et al., 1991; Cadrin et al.,
1995).  However, these studies have focused on
changes in hepatocytes or Kupffer cells, so little
is known about changes in dendritic cells (DC)
in the liver.
DC are professional antigen-presenting
cells, which contribute to the initiation of T
cell-mediated immune responses.  DC are
intimately related to the liver in both normal
and pathological conditions.  Recently, DC
have been shown to migrate from the blood to
the lymph via the hepatic sinusoids (Matsuno et
al., 1996; Kudo et al., 1997).  It appears that this
is the major migration pathway for DC from the
blood, and Kupffer cells play an important role
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in this migration (Matsuno et al., 1996; Suda et
al., 1996; Kudo et al., 1997).  In addition, DC
have been suggested to infiltrate into the liver
tissues and then play a pivotal role in the de-
velopment of chronic inflammatory liver dis-
eases such as primary biliary cirrhosis, chronic
hepatitis type B and type C, and autoimmune
hepatitis (van den Oord et al., 1990; Kaji et al.,
1997; Shinomiya et al., 1998; Tanimoto et al.,
1999).  However, there have been no attempts
to quantify changes in hepatic DC or Kupffer
cells in protoporphyric liver injury.  Therefore,
we examined changes in the numbers of these
cells in griseofulvin-induced protoporphyric
mice using immunohistochemistry to determine
whether protoporphyric liver injury affects
these cells and to speculate on the pathological
role of these cells, particularly hepatic DC, in
protoporphyric liver injury.
Materials and Methods
Twenty-nine male ICR mice, 5 weeks old and
weighing about 30 g, were fed a powdered diet
containing 3.5% griseofulvin (Sigma Chemical
Co., St. Louis, MO) and water ad libitum.  They
were analyzed at 1 (n = 5), 2 (n = 5), 3 (n = 5), 4
(n = 5), 6 (n = 5) and 8 (n = 4) weeks after the
commencement of griseofulvin feeding.  Eight
male ICR mice, 5 (n = 5) and 13 (n = 3) weeks
old on a powdered diet without griseofulvin,
served as controls.  The 13-week-old control
mice were the same age as the mice fed griseo-
fulvin for 8 weeks.  Animals were weighed and
killed under diethyl ether anesthesia.  The liver,
spleen and lung were removed and the liver was
weighed.  Small pieces of these specimens were
processed for histological and immunohisto-
chemical studies.
Liver tissues were fixed in 10% formalin
and processed using standard histological meth-
ods to yield paraffin sections 4 µm thick stained
with hematoxylin and eosin.
Specimens of the liver, spleen and lung were
snap-frozen in OCT medium with liquid nitro-
gen.  Cryostat sections 4 µm thick were fixed in
acetone for 10 min and single or double im-
munostaining was carried out.  The single im-
munostaining method was as follows.  After
blocking nonspecific binding with 1% bovine
serum albumin (BSA) in phosphate-buffered
saline (PBS, pH 7.4) for 10 min and then with
avidin-biotin blocking kit (Vector Laboratories,
Burlingame, CA), liver sections were incubated
with rat anti-mouse macrophage monoclonal
antibody F4/80 (diluted 1:50; Serotec, Oxford,
United Kingdom) and those of the spleen and
lung were incubated with rat anti-mouse den-
dritic cell monoclonal antibody NLDC-145 (di-
luted 1:25; Serotec) for 60 min (Austyn and
Gordon, 1981; Witmer-Pack et al., 1995).  Bound
monoclonal antibody was detected with bio-
tinylated rabbit anti-rat IgG (diluted 1:200 for
F4/80, 1:1000 for NLDC-145; Vector) for 30 min.
The sections were then treated with avidin-
biotin-alkaline phosphatase complex (Vectastain
ABC-AP Kit; Vector) for 30 min and labeled
cells were colored red with alkaline phospha-
tase substrate kit I (Vector Red; Vector).  Sec-
tions were counterstained with hematoxylin and
mounted in Aquatex (Merck, Darmstadt, Germany).
Since NLDC-145 recognizes not only DC but
also proliferating bile ductules, we performed
double immunostaining of the liver using anti-
keratin antibody as follows to distinguish these
structures.  Endogenous peroxidase activity was
eliminated by treatment with 1% H2O2 and 0.1%
NaN3 for 10 min.  After blocking nonspecific
binding with 1% BSA in PBS for 10 min, the
sections were incubated with rabbit polyclonal
anti-keratin, Wide Spectrum Screening (diluted
1:600; Dako, Carpinteria, CA) for 30 min to
label the bile ductules (Shiojiri, 1994).  The
reaction of the antibody was detected using goat
anti-rabbit immunoglobulin conjugated to
peroxidase labeled-dextran polymer (Dako
EnVision+; Dako) for 30 min and labeled cells
were colored brown with 3,3'-diaminobenzidine
tetrachloride (Dojin Chemical, Kumamoto,
Japan).  The sections were then treated with 5%
normal rabbit serum in PBS for 20 min and with
avidin-biotin blocking kit.  Then, they were
reacted with NLDC-145 and processed by the
indirect immunoalkaline phosphatase method
as described above.  On double immunostain-
ing, hepatic DC (red) could be distinguished
from bile ductules (brown).
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The number of NLDC-145-positive DC was
quantified by counting cells per unit area on the
sections in a blinded fashion, and the density of
these cells was determined.  Since the protopor-
phyric liver showed prominent hepatomegaly,
we considered that hypertrophy of hepatocytes
decreased the density of NLDC-145-positive
DC.  Therefore, we calculated the index of the
number of DC in the whole liver as follows.  We
multiplied cell density (/mm2) by liver weight
(g) in each mouse and calculated the mean
value of the products in each stage.  Then the
ratio of the value to that of the 5-week-old
controls was evaluated.  On the other hand, to
quantify the density of Kupffer cells, we count-
ed the number of F4/80-positive cells only in
the sinusoidal area and excluded macrophages
in the portal area in randomly selected fields.
Since Kupffer cells were counted only in the
sinusoidal area, we could not estimate the
changes in Kupffer cell number in the whole
liver.  In these analyses, only the labeled cells
where the nucleus could be identified were
counted.
The density of hepatic DC and Kupffer cells
was analyzed using the Mann-Whitney U test.
A P value < 0.05 was taken to indicate statis-
tical significance.
Results
Griseofulvin-induced protoporphyric mice
showed retardation of growth.  Mean body
weight of these mice at 8 weeks was about 80%
of that of the 13-week-old controls (Fig. 1).
These mice showed prominent hepatomegaly,
with the liver being dark brown in color.  The
livers of the mice fed griseofulvin for 8 weeks
were about 3.6-fold as heavy as those of the 13-
week-old controls (Fig. 1).
The intensity of histopathological changes
in the liver gradually increased over the experi-
mental period (Fig. 2).  Hepatocytes showed
nuclear and cytoplasmic hypertrophy, and
vacuolated cytoplasm.  Focal necrosis in the
parenchyma occurred at all stages.  Brown pig-
ment deposits appeared 1 week after the com-
mencement of griseofulvin feeding.  They accu-
mulated in hepatocytes, Kupffer cells, portal
macrophages, bile ducts and bile duct-
ules.  Plugs of the brown pigment fre-
quently obstructed the bile ducts and
ductules.  Proliferation of bile duct-
ules was obvious at 3 weeks and be-
came marked after 4 weeks.  This was
accompanied by a variable number of
connective tissue elements and infil-
tration of neutrophils and mono-
nuclear cells as reported previously
(Weston-Hurst and Paget, 1963;
Gschnait et al., 1975).  These changes,
the proliferation of bile ductules ac-
companied by inflammatory infiltra-
tion and connective tissue elements,
are similar to so-called “ductular reac-
tion”.  After 4 weeks of griseofulvin
feeding, this ductular reaction became
a marked pathological change in the
injured liver.  It extended from the
portal tracts toward neighboring por-
tal tracts and penetrated the paren-
chyma between the liver cell plates.
Fig. 1.  Body weight (BW) and liver weight (LW) in control
and griseofulvin-treated mice.  Data are expressed as mean ±
SD.  Bars represent SD.  C, 13-week-old control mice, iden-
tical in age to the mice treated with griseofulvin for 8 weeks.
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Fig. 2.  Light micrographs of the liver of a
mouse fed griseofulvin for 8 weeks.  Hema-
toxylin and eosin.  a:  Brown pigment de-
posits are accumulated in the liver tissue.
Central (arrow) and interlobular (arrow-
head) veins are visible.  × 120.  b: Hepato-
cytes show hypertrophy.  The proliferation
of bile ductules is accompanied by inflam-
matory infiltrate and connective tissue
elements, similarly to the so-called “duc-
tular reaction”.  It penetrates the paren-
chyma between the liver cell plates (arrow-
heads).  Note brown pigment deposits in the
bile ductules (arrows).  × 250.
Fig. 3.  Double immunostaining of the liver
with monoclonal antibody NLDC-145 (red)
and polyclonal anti-keratin, Wide Spectrum
Screening (brown).  a: A 5-week-old con-
trol mouse.  Several NLDC-145-positive
dendritic cells (DC) are visible in the portal
area (arrows).  × 500.  b: A mouse treated
with griseofulvin for 8 weeks.  The number
of NLDC-145-positive DC (arrow) is obvi-
ously decreased.  Proliferating bile ductules
are colored brown.  × 500.
a
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Fig. 5.  Changes in the index of the number of DC in the whole liver after griseofulvin feeding.  The mean
value of the products [cell density (/mm2) by liver weight (g)] was calculated in each stage, and the ratio of the
value to that of the 5-week-old controls was evaluated.  After 6 weeks, the index falls sharply.  C, 13-week-old
control mice.
Fig. 4.  Changes in the density of NLDC-145-positive DC in
the liver after griseofulvin feeding.  The density is signifi-
cantly decreased after 1 week.  Data are expressed as mean ±
SD.  Bars represent SD.  C, 13-week-old control mice.
In the control liver, NLDC-145-
positive hepatic DC were located main-
ly in the portal area and were rarely
seen in the parenchyma (Fig. 3a).  The
density of these hepatic DC gradually
decreased with the duration of griseo-
fulvin feeding (Fig. 4).  After 6 weeks,
the DC disappeared in most of the
portal area (Fig. 3b), and the density of
the hepatic DC was less than 10% of
that in the controls (Fig. 4).  However,
the index of the number of DC in the
whole liver showed a different course
of changes, increasing slightly until 4
weeks, but falling sharply at 6 weeks
(Fig. 5).
On the other hand, F4/80-positive
cells in the control liver were scattered
in the hepatic parenchyma and the por-
tal area (Fig. 6a).  Accumulation of
macrophages in the portal area was ob-
vious at 3 weeks of griseofulvin feed-
ing, but the increase in the density of
Kupffer cells in the sinusoidal area was
relatively gradual (Fig. 7).  At 8 weeks on the
griseofulvin diet, Kupffer cells were sometimes
hypertrophic, and clusters of Kupffer cells often
contained brown pigment deposits (Fig. 6b).  In
this stage, the density of Kupffer cells was
significantly increased (Fig. 7).
In the spleen and lung, no significant dif-
ferences were noted in the distribution of
NLDC-145-positive DC between experimental
and control mice (Figs. 8 and 9).  These DC
were located mainly in the periarterial
lymphoid sheath in the spleen, and studded the
lung parenchyma.
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Discussion
This study showed a decrease in density of
NLDC-145-positive hepatic DC and an in-
crease in that of F4/80-positive Kupffer cells in
griseofulvin-induced protoporphyric liver in-
jury.
The decrease in density of hepatic DC indi-
cated a reduction of hepatic DC per unit volume
of the liver.  However, this change does not im-
ply a decrease in number in the whole liver.
Hepatomegaly, an increase in the volume of the
liver, might be responsible for the decrease in
density of hepatic DC.  Therefore, we calculat-
ed the index of the number of DC in the whole
liver.  Hepatic DC number in the whole liver
appeared to increase slightly until 4 weeks of
griseofulvin treatment and fell sharply after 6
Fig. 6.  Immunostaining of the liver with monoclonal antibody F4/80 for Kupffer cells (red).  a: A 5-week-old
control mouse.  F4/80-positive Kupffer cells are distributed in the sinusoid.  × 250.  b: A mouse treated with
griseofulvin for 8 weeks.  F4/80-positive Kupffer cells are hypertrophic and markedly increased in number.
Note clusters of Kupffer cells containing brown pigment deposits (arrows).  × 250.
weeks.  These results suggested that the de-
crease in density of hepatic DC was due to hep-
atomegaly until 4 weeks of treatment, and was
substantial after 6 weeks.
In contrast to the decrease in number of
hepatic DC, there were no definite changes in
the distribution of NLDC-145-positive DC in
the spleen or lung.  This implied that the de-
crease in number of NLDC-145-positive DC
was specific in the liver.  To evaluate these ob-
servations, we considered the results of previ-
ous reports showing the behavior of circulating
DC and turnover time of tissue DC.  Intra-
venously transferred DC migrate mainly to the
liver and spleen, and partly to the lungs and
other organs (Fossum, 1988; Kupiec-Weglinski
et al., 1988; Suda et al., 1996).  A physiological
study further showed that the turnover time of
mouse splenic DC is 8–11 days (Steinman et al.,
1974).  If the decrease of hepatic DC
was due to a reduction in number of
circulating DC, splenic DC should
have decreased in number in the later
stage.  However, splenic DC showed
no definite changes after 8 weeks of
griseofulvin feeding, suggesting that
the number of circulating DC does not
decrease in protoporphyric mice at
least until about 2 months.  Accord-
ingly, it is reasonable to speculate that
some changes that occurred in the in-
jured liver caused the specific decrease
in hepatic DC number in protopor-
phyric mice.
The liver is an important organ for
blood DC to migrate to the lymph.
Blood DC attach to the vessel wall in
the sinusoidal area, pass through the
space of Disse to the connective tissue
stroma of either the portal or hepatic
vein area, and then enter the initial
lymphatic ducts accumulating in the
regional hepatic lymph nodes via the
afferent lymph (Kudo et al., 1997).  It
a
b
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Fig. 8.  NLDC-145-positive DC in the spleen of a 5-week-old control mouse (a) and a mouse treated with
griseofulvin for 8 weeks (b).  There are no significant differences in the distribution of splenic DC between
the control and experimental animals.  The splenic DC are distributed in the periarterial lymphoid sheath
(arrows).  × 280.
Fig. 7.  Changes in the density of F4/80-positive Kupffer
cells after griseofulvin feeding.  The density of these cells
shows a significant increase at 8 weeks.  Data are expressed
as mean ± SD.  Bars represent SD.  C, 13-week-old control
mice.
is probably important for migration
that the normal hepatic structure and
function are maintained.  Alteration of
liver structure after 4 weeks of
griseofulvin feeding might interrupt
the migration pathway and sub-
sequently cause the decrease of DC in
the whole liver.  After 4 weeks of
griseofulvin feeding, marked ductular
reaction occurred in the injured liver
(Shapiro and Wessely, 1984).  This
reaction is a characteristic change
observed in the cholestasis of bile duct
obstruction (Slott et al., 1990; Desmet,
1995; Roskams and Desmet, 1998).
Recently, Tanimoto et al. (1999) re-
ported that DC numbers were ex-
tremely low in the livers of patients
with large bile duct obstruction.  This
implies that ductular reaction might
cause a decrease in number of DC in
the whole liver.  However, ductular re-
action has also been shown to occur in
other liver diseases in which hepatic
DC increase in number (Popper, 1986;
Roskams and Desmet, 1998).  There-
fore, we could not conclude that the
ductular reaction we found led to a de-
crease of hepatic DC in protoporphyric
mice.
DC have been suggested to infil-
trate the liver and then play a pivotal
role in the development of chronic in-
flammatory liver diseases such as pri-
mary biliary cirrhosis, chronic hepatitis
type B and type C, and autoimmune
hepatitis (van den Oord et al., 1990;
Kaji et al., 1997; Shinomiya et al.,
1998; Tanimoto et al., 1999).  In con-
trast, hepatic DC seem to have no sig-
nificant relation to the progression of
griseofulvin-induced protoporphyric
liver injury as these cells decreased in
number in this type of liver injury.
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These observations raise the question of
whether the decrease in hepatic DC number af-
fects the immune system in protoporphyric
mice.  Previous studies showed that griseofulvin-
treated mice were susceptible to bacterial infec-
tion (Weston-Hurst and Paget, 1963; Mitchell
et al., 1973), and suggested a selective depress-
ing effect of griseofulvin on the cellular im-
mune response in mice (Mitchell et al., 1973).
Recently, Matsuno et al. (1996) suggested that
DC phagocytosed intravenously injected parti-
cles in the blood marginating pool and trans-
located from the sinusoidal area to the hepatic
lymph, and these cells might initiate immune
responses against pathogenic organisms such as
bacteria and fungi.  The susceptibility to bacte-
rial infection and the depression of the cellular
immune response in griseofulvin-treated mice
might be due to the decrease in
number of hepatic DC.
In protoporphyric mice, Kupffer
cells are activated to phagocytose pro-
toporphyrin crystals (Gschnait et al.,
1975).   However,  quanti tat ive
analysis of Kupffer cells has not been
performed.  There are no precise
markers for mouse Kupffer cells.  In
this study, we used a monoclonal
antibody, F4/80, which recognizes
macrophages including Kupffer cells
in mice.  To estimate the density of
Kupffer cells in the liver, we counted
the F4/80-positive cells only in the
s inuso ida l  a rea  and  exc luded
macrophages in the portal area.  Our
results showed that the density of
Kupffer cells gradually increased in
the injured liver.  Considering the
effect of hepatomegaly on the density
of Kupffer cells, the number of Kupffer
cells in the whole liver probably in-
creased more significantly than their
density revealed.  However, we could
not calculate the index of the number
of Kupffer cells in the whole liver
from the product of their density by
liver weight because they were
located only in the sinusoidal area.
Recently, it was reported that
Kupffer cells are involved in the migration of
hepatic DC; i.e. Kupffer cells were shown to be
capable of selectively trapping DC from the
blood (Suda et al., 1996; Kudo et al., 1997).  In
the present study, since densities of DC and
Kupffer cells showed opposite changes in the
injured liver, the decrease of hepatic DC seem-
ed to have no relation to Kupffer cells.  How-
ever, we could not eliminate the possibility that
Kupffer cells failed to trap circulating DC in the
protoporphyric liver.  Further studies are need-
ed to determine whether Kupffer cells in proto-
porphyric mice can trap DC from the blood.
In conclusion, we demonstrated a decrease
in number of hepatic DC and an increase in
number of Kupffer cells in protoporphyric liver
injury using an experimental mouse model and
immunohistochemical methods.  It seems that
Fig. 9.  NLDC-145-positive DC in the lung of a 5-week-old
control mouse (a) and a mouse treated with griseofulvin for 8
weeks (b).  In these sections, DC show a similar distribution in
the parenchyma (arrows).  × 280.
a
b
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the decrease in density of hepatic DC is due to
hepatomegaly until 4 weeks of griseofulvin
treatment, and is substantial after 6 weeks.
Alteration of the liver structure might cause this
substantial decrease in number of hepatic DC.
Although hepatic DC seemed to have no re-
lation to the progression of the griseofulvin-
induced protoporphyric liver injury, their de-
crease might affect the cellular immune re-
sponse in protoporphyria.
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